Dyes give us contrast, and contrast improves safety.
In the operating theatres of Adelaide and beyond, surgeons working at the very threshold of human sight are finding that what they can see determines what they can safely do. Dr Devaraj Supramaniam, a vitreoretinal specialist, has moved his practice toward formally approved surgical dyes — tools that render the invisible visible in one of medicine's most unforgiving spaces. The shift from improvised, off-label solutions to rigorously tested products like Bausch + Lomb's BLutein range reflects a broader reckoning in medicine: that precision is not only a matter of skill, but of the conditions we create for skill to operate safely.
- Vitreoretinal surgery unfolds millimetres from the tissue that governs sight, where transparent structures offer no natural contrast and the margin for catastrophic error is vanishingly thin.
- For years, surgeons accepted the risk of using dyes never designed or tested for use inside the eye — a quiet compromise that the field has been slow to abandon.
- BLutein's two-product system — one staining the vitreous, one binding to retinal membranes with high affinity and rapid clearance — transforms what was once an act of surgical faith into a controlled, visible procedure.
- Surgeons training the next generation now have a tool that makes the learning curve less dangerous, giving fellows the visual feedback that experience alone cannot substitute.
- The slightly higher cost of approved dyes is, in Supramaniam's view, not a trade-off at all — better visibility produces better outcomes, and in a field measured in fractions of a millimetre, that calculus is straightforward.
Dr Devaraj Supramaniam operates at the back of the eye, in a space where the structures he must manipulate are often transparent even under magnification. For much of the history of vitreoretinal surgery, navigating this terrain meant relying on intuition and accumulated experience — a kind of skilled blindness. Surgical dyes change that equation. By staining what would otherwise be invisible, they give the surgeon something concrete to work with.
The BLutein range from Bausch + Lomb addresses two distinct challenges. One product stains the vitreous humour itself — a substance that adheres to the retina like tape to paper, and which, if extracted without care, can tear the tissue beneath. Making it visible transforms a blind extraction into a deliberate one. The second product targets the thin membranes overlying the retina, binding to collagen with precision and clearing quickly, so the surgeon is not left managing a dye that spreads where it shouldn't. Both products are built around lutein, a pigment naturally present in the healthy retina, and both have undergone the formal safety testing that older, off-label alternatives never did.
For Supramaniam, who trains vitreoretinal fellows in the public system, the dyes are as much a teaching instrument as a surgical one. A trainee learning to peel a membrane from the retinal surface — by hand, under a microscope, millimetre by millimetre — needs to see what is happening. Without visual feedback, the learning curve is longer and the risks are higher. He likens the dyes to a blind-spot monitor: not a replacement for skill, but a meaningful extension of safety.
The cost is marginally higher than some alternatives. Supramaniam does not find this a difficult calculation. In a field where complications can mean permanent loss of vision, the value of seeing clearly is not a luxury — it is the point.
In the operating theatre, working millimetres from tissue that controls sight itself, there is almost no room for error. Dr Devaraj Supramaniam, a vitreoretinal surgeon based in Adelaide, operates in one of medicine's most delicate spaces—the back of the eye, where the structures he works with are often invisible to the naked eye, even under magnification. For decades, surgeons in his field relied on intuition, the subtle play of light, and accumulated experience to navigate this terrain. But intuition has limits, and experience alone cannot always compensate for what the eye cannot see.
This is where surgical dyes enter the picture. In vitreoretinal work, most of what needs operating on is transparent—the vitreous humour itself, the internal limiting membrane, the epiretinal membrane. Without contrast, a surgeon is essentially working blind, guided by feel and memory rather than sight. Supramaniam describes it plainly: dyes provide the visibility that transforms a procedure from an act of faith into an act of precision. They give the surgeon something to see.
For years, surgeons improvised. They used dyes off-label, products never formally tested or approved for use inside the eye. The risks were real but often accepted as the cost of doing business. Supramaniam's shift toward approved surgical dyes—specifically Bausch + Lomb's BLutein range—represents a deliberate move away from that compromise. The BLutein DYE300 stains the vitreous itself, making visible what would otherwise remain invisible. The BLutein DYE500 targets membranes, binding to collagen with high affinity and minimal spread into surrounding retinal tissue. Both products use naturally sourced lutein, a pigment already present in the healthy retina, known for its antioxidant and blue-light-filtering properties. But what matters most to Supramaniam is not the marketing story—it is that these products have been rigorously tested and formally approved for intraocular use.
The practical difference is significant. When removing the vitreous, a surgeon cannot simply suction it out. The vitreous adheres to the retina like sticky tape pressed against paper. Pull too hard and you tear the tissue beneath. Staining the vitreous with lutein crystals makes it visible, allows the surgeon to see exactly where it is and how it moves, and transforms a blind extraction into a controlled one. The membrane dye works differently. It stains with high affinity and clears quickly, so the surgeon does not need to leave it in the eye for extended periods. The contrast is vivid. The binding is strong. The risk of unintended spread is low.
Supramaniam trains vitreoretinal fellows in the public system, and he sees the dyes as essential teaching tools. A surgeon learning the craft needs to see what is happening. Without that visual feedback, the learning curve is steeper, the margin for error wider. He compares it to a blind-spot monitor in a car—once you have it, you realize how much safer it makes things. An experienced surgeon might manage without dyes, compensating through skill and years of practice. But dyes take safety to another level entirely. They are not a luxury; they are a step forward.
The cost is slightly higher than some alternatives, but Supramaniam is unequivocal about the trade-off. Better visibility means better outcomes. Safer surgery means fewer complications. For a surgeon working in both public and private settings, treating patients with complex retinal disease—visual distortion, reading difficulty, distance vision loss—the stakes are high. The work itself is incredibly fine: peeling a thin, delicate membrane from the retina surface by hand, under a microscope, millimetre by millimetre. The dyes do not make the work easy. They make it safer. And in a field where the margin for error is measured in fractions of a millimetre, safety is everything.
Citações Notáveis
For years we relied on intuition, subtle reflections and experience. But dyes give us contrast, and contrast improves safety.— Dr Devaraj Supramaniam
Like having a blind-spot monitor in your car—once it's there, you realise how much safer it makes things.— Dr Devaraj Supramaniam, on the value of dyes in surgical training
A Conversa do Hearth Outra perspectiva sobre a história
Why does visibility matter so much in this kind of surgery? Can't an experienced surgeon feel their way through it?
They could, and for years they did. But feeling your way through an operation on the retina is like trying to peel a sticker off paper in the dark. You might succeed, but the risk of tearing something irreplaceable is always there. Sight changes everything.
So the dyes are essentially making the invisible visible.
Exactly. The vitreous is transparent. The membranes are nearly colourless. A surgeon is working in a space where the structures they need to see are naturally invisible. Dyes solve that problem.
And the fact that these are approved for intraocular use—why is that such a big deal?
For decades, surgeons used dyes off-label, products never formally tested inside the eye. They worked, mostly, but there was always uncertainty about safety. Approved dyes have been rigorously tested. You know what you're putting in the eye and what the risks actually are.
Does that change how surgeons teach the next generation?
Completely. A fellow learning the craft needs to see what's happening. Without that visual feedback, they're learning blind. With dyes, they can watch the membrane separate, see the vitreous move, understand the anatomy in real time. It makes them safer surgeons faster.
Is there a risk that surgeons become dependent on the dyes?
That's a fair question, but I'd frame it differently. A blind-spot monitor in your car doesn't make you a worse driver. It makes you safer. Once you have that tool, you realize how much it improves outcomes. That's not dependence—that's progress.